| Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. P Clements, P Lachenbruch, J Siebold, B White, S Weiner, R Martin, ... The Journal of rheumatology 22 (7), 1281-1285, 1995 | 1131 | 1995 |
| Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease MS Klempner, LT Hu, J Evans, CH Schmid, GM Johnson, RP Trevino, ... New England Journal of Medicine 345 (2), 85-92, 2001 | 1029 | 2001 |
| Novel evidence‐based systemic lupus erythematosus responder index RA Furie, MA Petri, DJ Wallace, EM Ginzler, JT Merrill, W Stohl, ... Arthritis Care & Research: Official Journal of the American College of …, 2009 | 519 | 2009 |
| High‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis: analysis of a two‐year, double‐blind, randomized, controlled clinical trial PJ Clements, DE Furst, WK Wong, M Mayes, B White, F Wigley, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 453 | 1999 |
| A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease LH Sigal, JM Zahradnik, P Lavin, SJ Patella, G Bryant, R Haselby, E Hilton, ... New England Journal of Medicine 339 (4), 216-222, 1998 | 453 | 1998 |
| Randomized, double‐blind, placebo controlled trial of low‐dose pulse methotrexate in psoriatic arthritis RF Willkens, HJ Williams, JR Ward, MJ Egger, JC Reading, PJ Clements, ... Arthritis & Rheumatism 27 (4), 376-381, 1984 | 421 | 1984 |
| Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon PA Merkel, K Herlyn, RW Martin, JJ Anderson, MD Mayes, P Bell, JH Korn, ... Arthritis & Rheumatism 46 (9), 2410-2420, 2002 | 419 | 2002 |
| Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high‐dose versus low‐dose penicillamine trial PJ Clements, EL Hurwitz, WK Wong, JR Seibold, M Mayes, B White, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 410 | 2000 |
| Laboratory evaluation in the diagnosis of Lyme disease P Tugwell, DT Dennis, A Weinstein, G Wells, B Shea, G Nichol, ... Annals of internal medicine 127 (12), 1109-1123, 1997 | 348 | 1997 |
| Lyme disease: an infectious and postinfectious syndrome. ES Asch, DI Bujak, M Weiss, MG Peterson, A Weinstein The Journal of rheumatology 21 (3), 454-461, 1994 | 318 | 1994 |
| Outcome assessment in clinical trials evidence for the sensitivity of a health status measure RF Meenan, JJ Anderson, LE Kazis, MJ Egger, M Altz‐Smith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1984 | 313 | 1984 |
| Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus R Furie, W Stohl, EM Ginzler, M Becker, N Mishra, W Chatham, JT Merrill, ... Arthritis research & therapy 10, 1-15, 2008 | 304 | 2008 |
| Predictors and outcomes of scleroderma renal crisis: the high‐dose versus low‐dose d‐penicillamine in early diffuse systemic sclerosis trial PJ DeMarco, MH Weisman, JR Seibold, DE Furst, WK Wong, EL Hurwitz, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 297 | 2002 |
| Cognitive function in post-treatment Lyme disease Do additional antibiotics help? RF Kaplan, RP Trevino, GM Johnson, L Levy, R Dornbush, LT Hu, ... Neurology 60 (12), 1916-1922, 2003 | 279 | 2003 |
| Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo‐controlled, double‐blind study FM Wigley, JH Korn, ME Csuka, TA Medsger Jr, NF Rothfield, M Ellman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 250 | 1998 |
| Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis JR Ward, H James Williams, MJ Egger, JC Reading, E Boyce, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1983 | 220 | 1983 |
| Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus EM Ginzler, DJ Wallace, JT Merrill, RA Furie, W Stohl, WW Chatham, ... The Journal of rheumatology 41 (2), 300-309, 2014 | 212 | 2014 |
| Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents O Onder, A Weinstein, LW Hoyer Blood 56 (2), 177-182, 1980 | 194 | 1980 |
| Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study D Khanna, DE Furst, RD Hays, GS Park, WK Wong, JR Seibold, ... Annals of the rheumatic diseases 65 (10), 1325-1329, 2006 | 179 | 2006 |
| A review of complement activation in SLE A Weinstein, RV Alexander, DJ Zack Current rheumatology reports 23, 1-8, 2021 | 171 | 2021 |
